Pellegrino Musto

Research interests

Publications

• Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

  The Lancet Oncology · 2023 · https://doi.org/10.1016/s1470-2045(23)00159-6

• Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

  The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(20)30251-9

• Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

  Blood Reviews · 2019 · https://doi.org/10.1016/j.blre.2019.01.001

• Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.72.6679

• High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders

  Tumor Biology · 2015 · 10.1007/s13277-015-3741-3

• Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.61.2267

• Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

  Blood · 2015 · https://doi.org/10.1182/blood-2014-12-615187

• European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

  Haematologica · 2015 · https://doi.org/10.3324/haematol.2014.117176

• Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1402888

• Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

  Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.52.0023

• Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(13)70609-0

• Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1208500

• Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

  Haematologica · 2012 · https://doi.org/10.3324/haematol.2012.072645

• Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

  Blood · 2012 · https://doi.org/10.1182/blood-2012-02-408898

• Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

  Blood · 2011 · 10.1182/blood-2011-03-341669

• Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

  Blood · 2011 · 10.1182/blood-2010-09-307645

• BRAF Mutations in Hairy-Cell Leukemia

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1014209

• Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.23.7172

• Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.29.8216

• Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

  Blood · 2010 · https://doi.org/10.1182/blood-2010-07-294983

• ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.17.0910

• Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

  Blood · 2008 · https://doi.org/10.1182/blood-2008-04-149427

• Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.12.3463

• Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

  The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(06)68338-4

• Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

  Blood · 2003 · https://doi.org/10.1182/blood-2002-10-3230

Current projects

No projects listed.